PTD unknown

Sydney - Friday - March 16: (RWE Australian Business News)...

  1. fluffynymph
    56,914 Posts.
    lightbulb Created with Sketch. 289
    clock Created with Sketch.
    16/03/07
    10:49
    Post #: 2274752
    Sydney - Friday - March 16: (RWE Australian Business News) -
    Australian biotechnology company, Peptech Limited (ASX: PTD; AIM: PTDx)
    today announced the implementation of a proprietary antibody based
    therapeutic technology platform, named Synhumanisation, which provides a
    competitive advantage by enabling therapeutic drugs to be developed
    against multiple medical targets.
    Synhumanisation is centred on the use of human-like antibody
    sequences in place of mouse sequences in order to avoid potentially
    harmful immune responses in humans. The Synhumanisation platform will
    result in increased discovery of patentable new antibody products.
    PTD Price at posting: 0.0¢ Sentiment: Buy Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Lithium hype is back. Just ignore the fact Jianxiawo only supplies 3% globally
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 32
right-arrow Created with Sketch.
NEWS What the hell is wrong with ASX Ltd? The hits keep coming, and now CBOE looms
right-arrow Created with Sketch.
NEWS Win a $12k Portfolio | 7%-10.25% low risk rental yield from a proven asset
right-arrow Created with Sketch.
NEWS Iress Ltd leads top gainers intraday Friday as Blackstone buyout bid confirmed
right-arrow Created with Sketch.
NEWS DroneShield's civilian counter-drone tech lands with a buzz
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.